-
srdr.ahrq.gov/projects/1671/studies/196193
January 01, 2009 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196194
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196106
January 01, 2002 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196104
January 01, 2017 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196108
January 01, 2002 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196203
January 01, 2016 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196099
January 01, 2017 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196114
January 01, 2005 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196126
January 01, 2011 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196137
January 01, 2018 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196132
January 01, 2018 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196141
January 01, 2007 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196120
January 01, 2009 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196135
January 01, 2010 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196131
January 01, 2008 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196133
January 01, 2012 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196140
January 01, 2008 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196109
January 01, 2001 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196128
January 01, 2002 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196138
January 01, 2016 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?